| For: | Beyer AP, Moise PA, Wong M, Gao W, Xiang C, Shen P, Pavlakis M, Vincenti F, Wang W. Clinical events and healthcare resource utilization associated with neutropenia and leukopenia among adult kidney transplant recipients receiving valganciclovir. World J Transplant 2025; 15(2): 102671 [PMID: 40535505 DOI: 10.5500/wjt.v15.i2.102671] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v15/i2/102671.htm |
| Number | Citing Articles |
| 1 |
Ilkka Helanterä, Fernanda Ortiz, Essi Havula, Samuli Tuominen, Markus Hakamäki, Tapio Hellman, Satu Mäkelä, Riku Korhonen. The frequency and timing of leukopenia and CMV infections in kidney transplant recipients in Finland – a retrospective observational study. Transplant International 2026; 39 doi: 10.3389/ti.2026.16893
|
| 2 |
Muhammad Usman, Zhihan Yuan, Hao Yu, Xutao Chen, Zhuang Tang, Cheng Liu, Zhouhang Li, Wang He, Kewei Xu. Beyond valganciclovir: A meta-analysis of letermovir’s safety and efficacy in cytomegalovirus prophylaxis after solid organ transplantation. BMC Infectious Diseases 2026; 26(1) doi: 10.1186/s12879-026-13022-1
|
| 3 |
David J. Taber, Hannah Culpepper, Courtney E. Harris, Neha Patel, Morgan Overstreet, Felicia Bartlett, Sakshi Vaishnav, Maria Aurora Posadas Salas, Santosh Nagaraju, Steve Hanish. Single-center, open-label, randomized controlled trial comparing the tolerability of maribavir 400 mg twice daily versus standard-dose valganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients. American Journal of Transplantation 2026; doi: 10.1016/j.ajt.2026.05.729
|